House
GuidelinesCalculatorsPricingBlog
Ask House ↗
Guidelines↗Calculators↗Pricing↗Blog↗
House
Clinical AIRoundsGuidelinesCalculatorsPricingBlogAboutEditorial policyPrivacyTermsLog in ↗
Clinical intelligence, for physicians.© 2026 House
House
Clinical AIRoundsGuidelinesCalculatorsPricingBlogAboutEditorial policyPrivacyTermsLog in ↗
Clinical intelligence, for physicians.© 2026 House
Back to guidelines
Hepatology

Liver: Malnutrition and Nutritional Recommendations in Liver Disease

ACG · 2025 edition / updateSource checked 29 October 2026
Read the source publication
House clinical summary

Scope

ACG nutrition guidance treats malnutrition as both deficient and imbalanced nutrition, including muscle loss concealed by obesity or fluid retention. The practical priorities are assessment, adequate food intake, timely supplementation and avoiding restrictions that worsen undernutrition. Disease-specific supplements remain adjuncts with their own limits; nutrition care does not replace treatment of the underlying liver disease.

Written by House with AI assistance · AI-assisted source check 29 October 2026.

This is House’s summary of the cited guidance. The source check is not an independent clinician review. Open the publication for complete recommendations, exceptions, evidence grades and later amendments.

Look beyond weight when assessing nutrition

  • Assess all patients with cirrhosis for frailty or sarcopenia using appropriate diagnostic methods to guide nutrition care. Muscle loss can coexist with obesity, while ascites and oedema can mask weight loss; apparently adequate weight does not exclude malnutrition. [1]
  • Combine body-composition assessment with function where appropriate. Handgrip strength may help predict outcomes but is not a direct substitute for muscle mass or nutritional status; waist circumference cannot assess nutritional status reliably when ascites distorts it. [1]
  • Monitor people with chronic liver disease for anorexia, poor-quality intake and malnutrition, and intervene when identified. In alcohol-associated liver disease, especially alcohol-associated hepatitis, specifically assess dietary adequacy. [1]
  • Use structured programmes to identify and treat sarcopenia around liver transplantation. Dietitians and multidisciplinary care are appropriate because nutritional problems and disease severity interact. [1]

Provide nutrition early and reduce prolonged fasting

  • Consider early oral or enteral nutrition supplementation for hospitalised patients with cirrhosis (conditional, low-certainty evidence). For cirrhosis or alcohol-associated hepatitis more generally, nutritional supplementation is also suggested, with very low-certainty evidence. [1]
  • Include a late-evening snack for patients with cirrhosis to support lean tissue and nutritional status and reduce complications such as ascites and encephalopathy (strong, moderate certainty). This should complement the overall nutrition plan rather than substitute for regular meals. [1]
  • For cirrhosis, small meals or snacks every 3–4 hours while awake can help sustain intake. Tailor the evening snack to glucose control and reflux symptoms, which can worsen when food is taken too close to bedtime. [1]

Preserve protein and use supplements as adjuncts

  • Do not restrict dietary protein in decompensated cirrhosis with hepatic encephalopathy (conditional, very low certainty). Restriction worsens malnutrition and muscle loss and can impair extrahepatic ammonia disposal. [1]
  • Consider enriching the diet with vegetarian protein sources in patients with cirrhosis and encephalopathy who require nutrition supplementation (conditional, low certainty). This guidance concerns the protein source, not reducing total protein intake. [1]
  • Where available, add branched-chain amino acids to standard care in cirrhosis with hepatic encephalopathy (strong, moderate certainty). They are adjuncts, not replacements for established encephalopathy treatment; the review found benefit for oral supplementation, with no significant benefit for intravenous formulations in the pooled trials. [1]

Address deficiencies without indiscriminate supplementation

  • Recognise thiamine deficiency in chronic alcohol misuse or cirrhosis. Suspected Wernicke encephalopathy is an acute emergency requiring prompt treatment, usually intravenous thiamine; this summary does not provide its complete dosing regimen. [1]
  • Consider vitamin D supplementation when a person with chronic liver disease has a low vitamin D level. The guideline describes limited evidence and possible bone and liver benefits, rather than established universal protection against liver complications. [1]
  • Consider zinc in liver disease with hypozincaemia or clinical signs of deficiency. If prescribed, the discussion advises no more than 50 mg elemental zinc orally daily, taken with a meal to reduce nausea and copper-deficiency risk. [1]
  • Use vitamin A supplementation cautiously in liver disease. Reduced hepatic production of its carrier protein can increase toxicity risk, so a low serum vitamin A result is not a reason for unmonitored high-dose treatment. [1]

Combine diet and activity with selective adjuncts

  • Encourage diet and exercise for MASH across disease severities. Lifestyle change supports cardiometabolic health, but the evidence for reversal of hepatic fibrosis is limited and sustained support is important. [1]
  • ACG conditionally suggests natural vitamin E 800 IU daily for MASH without cirrhosis, with low-certainty evidence. Discuss potential long-term harms before initiation; histological improvement does not establish an antifibrotic benefit. [1]
  • Discuss the reported bleeding, haemorrhagic-stroke and prostate-cancer signals when considering high-dose vitamin E for noncirrhotic MASH. The source states that these signals have not been confirmed in prospective studies; present uncertainty alongside potential benefit. [1]
  • Consider coffee, preferably at least 2 cups daily, in chronic liver disease to reduce fibrosis-progression or HCC risk (conditional, low certainty). This is an adjunctive suggestion, not a guarantee of protection or a replacement for disease-specific care. [1]
  • Reduce dietary fructose as part of chronic liver disease nutrition care, consistent with the source’s ungraded key concept. This is not a recommendation for a nutritionally inadequate restrictive diet. [1]

Avoid treating dietary restriction as a universal rule

  • For cirrhosis with ascites treated with diuretics, this guideline makes no recommendation for or against strict sodium restriction because evidence is insufficient. Balance ascites management with palatability and adequate nutritional intake; do not present this uncertainty as proof that unrestricted sodium is safe for everyone. [1]
  • Fluid restriction is not routinely required solely for ascites. Hyponatraemia may require a separate individual fluid plan; assess sodium and the clinical setting rather than applying a blanket restriction to every patient with cirrhosis. [1]

Limitations and use

  • This focused summary does not supply an individual calorie/protein prescription, feeding-tube protocol or full micronutrient replacement regimen. Dietitian assessment is needed for nutritional targets and monitoring.
  • The vitamin E recommendation is specific to this ACG guideline and noncirrhotic MASH; compare current disease-specific options and discuss uncertain long-term harms.
  • Evidence for several supplements and restrictions is limited. Oral and intravenous supplements are not interchangeable, and nutrition measures do not replace standard encephalopathy or ascites treatment.

This summary is selective and does not reproduce every recommendation. Apply the source’s population, setting and eligibility criteria, together with clinical judgement and local policy.

Summary sources

  1. 1
    Liver: Malnutrition and Nutritional Recommendations in Liver Disease

    Selected recommendation material consulted

Original guideline

Publication details

Issuing organisation
ACG
Resource type
Clinical guideline · House clinical summary

The source check confirms publication details and the linked edition. It does not certify every recommendation or its suitability for an individual patient. Publisher access conditions may apply.

On this page

  • Scope
  • Look beyond weight when assessing nutrition
  • Provide nutrition early and reduce prolonged fasting
  • Preserve protein and use supplements as adjuncts
  • Address deficiencies without indiscriminate supplementation
  • Combine diet and activity with selective adjuncts
  • Avoid treating dietary restriction as a universal rule
  • Limitations and use
  • Summary sources
  • Publication details
House
Clinical AIRoundsGuidelinesCalculatorsPricingBlogAboutEditorial policyPrivacyTermsLog in ↗
Clinical intelligence, for physicians.© 2026 House